A phase II, randomized, doubleblind, parallelgroup, placebocontrolled oral food challenge trial of Xolair (omalizumab) in peanut allergy

Journal of Allergy and Clinical Immunology

Volumn 127, Issue 5, 2007, Pages 1309-1310.e1

  Sampson, Hugh A ^a   Leung, Donald Y M ^b   Burks, A Wesley ^c   Lack, Gideon ^d   Bahna, Sami L ^e   Jones, Stacie M ^f   Wong, Dennis A ^g  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d ST MARY S HOSPITAL   (United Kingdom)

^e LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^f UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^g GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; OMALIZUMAB; PLACEBO;

ADOLESCENT; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LETTER; MALE; MULTICENTER STUDY; PEANUT ALLERGY; PHASE 2 CLINICAL TRIAL; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SKIN TEST; UNSPECIFIED SIDE EFFECT;

EID: 79952303048     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.01.051     Document Type: Article

References (7)

1. S.H. Sicherer, and H.A. Sampson Peanut allergy: emerging concepts and approaches for an apparent epidemic J Allergy Clin Immunol 120 2007 491 503 (Pubitemid 47320772)
2. M.P. Ross, M. Ferguson, D. Street, K. Klontz, T. Schroeder, and S. Luccioli Analysis of food-allergic and anaphylactic events in the National Electronic Injury Surveillance System J Allergy Clin Immunol 121 2008 166 171
3. J. Wang, and H.A. Sampson Food anaphylaxis Clin Exp Allergy 37 2007 651 660 (Pubitemid 46643052)
4. S.H. Sicherer, S.A. Noone, and A. Munoz-Furlong The impact of childhood food allergy on quality of life Ann Allergy Asthma Immunol 87 2001 461 464 (Pubitemid 34001033)
5. D.Y.M. Leung, H.A. Sampson, J.W. Yunginger, A.W. Burks, L. Schneider, and C.H. Wortel Effect of anti-IgE therapy in patients with peanut allergy N Engl J Med 348 2003 986 993 (Pubitemid 36302243)
6. S.M. Jones, L. Pons, J.L. Roberts, A.M. Scurlock, T.T. Perry, and M. Kulis Clinical efficacy and immune regulation with peanut oral immunotherapy J Allergy Clin Immunol 124 2009 292 300
7. K. Blumchen, H. Ulbricht, U. Staden, K. Dobberstein, J. Beschorner, and L.C. de Oliveira Oral peanut immunotherapy in children with peanut anaphylaxis J Allergy Clin Immunol 126 2010 83 91